Preventing PVCs to protect heart pumping function
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether treating frequent PVCs (extra heartbeats) can help protect the heart’s pumping strength in people who currently feel fine. It specifically looks at patients with a high PVC burden but normal heart function, using a preventative approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You have frequent PVCs, making up at least 10% of your heartbeats
- You currently have no symptoms from your PVCs
- Your heart pumping strength is preserved (left ventricular ejection fraction at least 55%)
- You are able and willing to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the medication flecainide can reduce frequent extra heartbeats (called PVCs) that come from normal heart tissue, and may help prevent or reverse heart muscle problems caused by these extra beats.
This study looks at adults with frequent extra heartbeats (PVCs) to better understand how myocarditis may be causing them. If you qualify, your care team may review your heart rhythm data and other heart imaging/testing to see how this condition relates to your symptoms and risk.
This trial tests a new way to treat rapid heartbeats from the lower chambers (ventricles) using a special catheter that delivers short electrical pulses to stop the abnormal signals. It may help people with extra beats (PVCs) or a fast heart rhythm (ventricular tachycardia) that needs treatment.
This study looks at how extra heartbeats (called premature ventricular complexes or PVCs) affect physical abilities. It compares people with troublesome PVCs to healthy volunteers to understand the impact on daily function.
This trial tests whether a gentle nerve-stimulation device worn on the ear can reduce dangerous heart-rhythm problems. There are two groups: one for people with frequent extra heartbeats (PVCs) and one for people with a defibrillator who have had repeated episodes of a more serious rhythm problem (VT).
This trial studies how a drug called adenosine helps doctors understand why premature ventricular contractions (PVCs) are happening. The goal is to guide treatment, including catheter ablation, for people with PVCs.
Hear when a new Premature Ventricular Contractions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.